6DECEMBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe silver lining of the pandemic is the rapid rate of transformative changes that really reshaped the pharma and life sciences field within a span of two years. The challenges forced the pharma professionals to entirely rethink their older ways of drug discovery and clinical trials methods, leading to exceptional innovations and progress. Without any doubt, the pharma sector is on its path to accommodate futuristic technological advancements that will greatly help in advancing their functionality. One such promising technology is `extended reality.' This combination of virtual reality, augmented reality, and mixed reality will overcome the traditional 2D challenges of the complex drug development processes while increasing the efficiency and comfort for both scientists and specialists and making their lives much easier and more convenient.Coupled with that, digital therapeutics is another anticipated trend for the innovation of the sector. These evidence-based therapeutic interventions will use software to manage and treat physical, mental, and behavioral conditions. These solutions will be used along with medications or therapies and are intended to offer every individual greater control over their health and outcomes.Similarly, in the coming years, there will be an increase in the use of digital biomarkers. With the help of AI, data science, digital medicine, and genomics, the digital biomarkers will track the symptoms of disease progression and medication adherence. The data collected will significantly help in driving measurable results and accurately predict outcomes of treatment.In this edition of Pharma Tech Outlook, we bring you the story of some of the top drug discovery and development solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best drug discovery and development solution providers according to your requirements.Let us know your thoughts!Reshaping Therapeutic Processes using Modern TechnologiesTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 20 - 2021, Vol 07 - Issue 20 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerJaxon JaseEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >